title: Adrenergic receptors and fat cells: differential recruitment by physiological amines and homologous regulation.
abstract: The control of fat cell lipolysis by the catecholamines involves at least four different adrenoceptor subtypes; three beta (beta 1-, beta 2-, and beta 3-ARs) and one alpha 2-adrenoceptor (alpha 2-AR). The physiological importance of the beta- and alpha 2A-ARs varies according to the species, the sex, the age, the anatomical location of fat deposits and the degree of obesity in humans and animals. The physiological amines operate through differential recruitment of these sites on the basis of their relative affinities. This point has been assessed by in vitro studies and has partly been confirmed in in vivo experiments using selected alpha/beta-AR antagonists and in situ microdialysis. The affinity of the beta 3-AR for catecholamines is less than that of the classical beta 1- and beta 2-ARs in the various species investigated. Conversely, it is the alpha 2-AR which exhibit the highest affinity for the physiological amines in all fat cells. The relative order of affinity of the various fat cell ARs for the physiological amines defined in binding studies and in vitro assays is alpha 2 > beta 1 > or = beta 2 > beta 3 for norepinephrine and alpha 2 > beta 2 > beta 1 > beta 3 for epinephrine. When considering differential beta-AR recruitment by catecholamines, it is the beta 1-AR which is always activated at the lowest norepinephrine levels, whatever the species, while the activation of the beta 3-AR requires higher norepinephrine levels. In addition to the differential recruitment, differential regulation by hormones could also occur for each fat cell AR subtype. The alpha 2-and beta 3-ARs are less prone to desensitization and down-regulation by comparison with the beta 1- and beta 2-AR.
authors.affiliation: Unité INSERM 317, Institut Louis Bugnard, CHU Rangueil, Toulouse, France.
authors.forename: M
authors.initials: M
authors.lastname: Lafontan
authors.forename: A
authors.initials: A
authors.lastname: Bousquet-Melou
authors.forename: J
authors.initials: J
authors.lastname: Galitzky
authors.forename: P
authors.initials: P
authors.lastname: Barbe
authors.forename: C
authors.initials: C
authors.lastname: Carpéné
authors.forename: D
authors.initials: D
authors.lastname: Langin
authors.forename: M
authors.initials: M
authors.lastname: Berlan
authors.forename: P
authors.initials: P
authors.lastname: Valet
authors.forename: I
authors.initials: I
authors.lastname: Castan
authors.forename: A
authors.initials: A
authors.lastname: Bouloumié
mesh_terms: D017667:Adipocytes / Q000502:physiology*; D000818:Animals; D001679:Biogenic Amines / Q000502:physiology*; D006706:Homeostasis; D006801:Humans; D008954:Models, Biological; D011942:Receptors, Adrenergic, alpha / Q000502:physiology*; D011943:Receptors, Adrenergic, beta / Q000502:physiology*; D013045:Species Specificity
chemical_list: D001679:Biogenic Amines; D011942:Receptors, Adrenergic, alpha; D011943:Receptors, Adrenergic, beta